Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

Triple-negative breast cancer (TNBC) poses a significant clinical challenge due to its propensity for metastasis and poor prognosis. TNBC evades the body’s immune system recognition and attack through various mechanisms, including the Janus Kinase 2 (JAK2)/signal transducer and activator of transcri...

Full description

Bibliographic Details
Main Authors: Lin Long, Xiangyu Fei, Liucui Chen, Liang Yao, Xiaoyong Lei
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
receptor tyrosine kinase
Janus Kinase 2
signal transducer and activator of transcription 3
small molecule compounds
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1381251/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1381251/full

Similar Items